Cargando…
Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1
Autoimmune polyendocrine syndrome type 1 (APS1) is a monogenic disorder that features multiple autoimmune disease manifestations. It is caused by mutations in the Autoimmune regulator (AIRE) gene, which promote thymic display of thousands of peripheral tissue antigens in a process critical for estab...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735587/ https://www.ncbi.nlm.nih.gov/pubmed/26830021 http://dx.doi.org/10.1038/srep20104 |
_version_ | 1782413103430893568 |
---|---|
author | Landegren, Nils Sharon, Donald Freyhult, Eva Hallgren, Åsa Eriksson, Daniel Edqvist, Per-Henrik Bensing, Sophie Wahlberg, Jeanette Nelson, Lawrence M. Gustafsson, Jan Husebye, Eystein S. Anderson, Mark S. Snyder, Michael Kämpe, Olle |
author_facet | Landegren, Nils Sharon, Donald Freyhult, Eva Hallgren, Åsa Eriksson, Daniel Edqvist, Per-Henrik Bensing, Sophie Wahlberg, Jeanette Nelson, Lawrence M. Gustafsson, Jan Husebye, Eystein S. Anderson, Mark S. Snyder, Michael Kämpe, Olle |
author_sort | Landegren, Nils |
collection | PubMed |
description | Autoimmune polyendocrine syndrome type 1 (APS1) is a monogenic disorder that features multiple autoimmune disease manifestations. It is caused by mutations in the Autoimmune regulator (AIRE) gene, which promote thymic display of thousands of peripheral tissue antigens in a process critical for establishing central immune tolerance. We here used proteome arrays to perform a comprehensive study of autoimmune targets in APS1. Interrogation of established autoantigens revealed highly reliable detection of autoantibodies, and by exploring the full panel of more than 9000 proteins we further identified MAGEB2 and PDILT as novel major autoantigens in APS1. Our proteome-wide assessment revealed a marked enrichment for tissue-specific immune targets, mirroring AIRE’s selectiveness for this category of genes. Our findings also suggest that only a very limited portion of the proteome becomes targeted by the immune system in APS1, which contrasts the broad defect of thymic presentation associated with AIRE-deficiency and raises novel questions what other factors are needed for break of tolerance. |
format | Online Article Text |
id | pubmed-4735587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-47355872016-02-05 Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1 Landegren, Nils Sharon, Donald Freyhult, Eva Hallgren, Åsa Eriksson, Daniel Edqvist, Per-Henrik Bensing, Sophie Wahlberg, Jeanette Nelson, Lawrence M. Gustafsson, Jan Husebye, Eystein S. Anderson, Mark S. Snyder, Michael Kämpe, Olle Sci Rep Article Autoimmune polyendocrine syndrome type 1 (APS1) is a monogenic disorder that features multiple autoimmune disease manifestations. It is caused by mutations in the Autoimmune regulator (AIRE) gene, which promote thymic display of thousands of peripheral tissue antigens in a process critical for establishing central immune tolerance. We here used proteome arrays to perform a comprehensive study of autoimmune targets in APS1. Interrogation of established autoantigens revealed highly reliable detection of autoantibodies, and by exploring the full panel of more than 9000 proteins we further identified MAGEB2 and PDILT as novel major autoantigens in APS1. Our proteome-wide assessment revealed a marked enrichment for tissue-specific immune targets, mirroring AIRE’s selectiveness for this category of genes. Our findings also suggest that only a very limited portion of the proteome becomes targeted by the immune system in APS1, which contrasts the broad defect of thymic presentation associated with AIRE-deficiency and raises novel questions what other factors are needed for break of tolerance. Nature Publishing Group 2016-02-01 /pmc/articles/PMC4735587/ /pubmed/26830021 http://dx.doi.org/10.1038/srep20104 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Landegren, Nils Sharon, Donald Freyhult, Eva Hallgren, Åsa Eriksson, Daniel Edqvist, Per-Henrik Bensing, Sophie Wahlberg, Jeanette Nelson, Lawrence M. Gustafsson, Jan Husebye, Eystein S. Anderson, Mark S. Snyder, Michael Kämpe, Olle Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1 |
title | Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1 |
title_full | Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1 |
title_fullStr | Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1 |
title_full_unstemmed | Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1 |
title_short | Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1 |
title_sort | proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735587/ https://www.ncbi.nlm.nih.gov/pubmed/26830021 http://dx.doi.org/10.1038/srep20104 |
work_keys_str_mv | AT landegrennils proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 AT sharondonald proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 AT freyhulteva proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 AT hallgrenasa proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 AT erikssondaniel proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 AT edqvistperhenrik proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 AT bensingsophie proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 AT wahlbergjeanette proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 AT nelsonlawrencem proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 AT gustafssonjan proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 AT husebyeeysteins proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 AT andersonmarks proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 AT snydermichael proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 AT kampeolle proteomewidesurveyoftheautoimmunetargetrepertoireinautoimmunepolyendocrinesyndrometype1 |